ARS Pharmaceuticals (SPRY) P/E ratio

PE ratio:

194.00+1.29(+0.67%)
2 min ago

Summary

  • As of today (May 9, 2025), SPRY price to earnings ratio is 194.00, with a rise of +1.29 (+0.67%) during the current trading session.
  • SPRY PE ratio is now -9.47% below its all-time high of 214.29.

Performance

SPRY PE ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherSPRYvaluation metrics

PE ratio Formula

P/E =  
Price
TTM Earnings Per Share

SPRY PE ratio Trends

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday+0.7%+0.7%+113.7%+3371.5%
1 m1 month+1.8%+1.8%--
3 m3 months+12.8%+13.9%+113.7%+3371.5%
6 m6 months--20.3%--
ytdytd+26.2%+28.7%--
1 y1 year-+54.3%+112.3%-
5 y5 years----

SPRY PE ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month214.29-9.5%176.14+10.1%
3 m3-month214.29-9.5%144.43+34.3%
6 m6-month214.29-9.5%142.71+35.9%
1 y1-year214.29-9.5%142.71+35.9%
3 y3-year214.29-9.5%142.71+35.9%
5 y5-year214.29-9.5%142.71+35.9%
alltimeall time214.29-9.5%142.71+35.9%

SPRY PE ratio History

DateValue
2025
194.00(+26.2%)
DateValue
2024
153.71

FAQ

  • What is ARS Pharmaceuticals price to earnings ratio?
  • What is the all time high PE ratio for ARS Pharmaceuticals?
  • What is SPRY price to earnings ratio year-to-date change?

What is ARS Pharmaceuticals price to earnings ratio?

The current PE ratio of SPRY is 194.00

What is the all time high PE ratio for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high price to earnings ratio is 214.29

What is SPRY price to earnings ratio year-to-date change?

ARS Pharmaceuticals price to earnings ratio has changed by +40.29 (+26.21%) since the beginning of the year
On this page